<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30254988</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">2234-943X</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>8</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Frontiers in oncology</Title>                <ISOAbbreviation>Front Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Cancer Incidence and Mortality Among Ethnic German Migrants From the Former Soviet Union.</ArticleTitle>            <Pagination>                <MedlinePgn>378</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fonc.2018.00378</ELocationID>            <Abstract>                <AbstractText>Germany is a country known for immigration. In 2015, 21% of the general population in Germany consisted of individuals with a migration background. This article focuses on cancer-specific incidence and mortality among one of the biggest migrant groups in Germany: the resettlers. Resettlers are ethnic Germans who mainly immigrated from the Russian federation and other countries of the former Soviet Union after its collapse in 1989. We investigated differences between resettlers and the general German population, regarding (i) incidence and mortality of malignant neoplasms, (ii) time trends of the corresponding incidence and mortality, and (iii) cancer stage at diagnosis. We provide data from two resettler cohorts covering an observation time of 20 years: one cohort on cancer incidence (<i>N</i> = 32,972), and another cohort on mortality (<i>N</i> = 59,390). Cancer-specific standardized incidence ratios (SIR) and standardized mortality ratios (SMR) for all malignant neoplasms combined and the most common cancer-sites were calculated between resettlers and the general German population. Time trend analyses using Poisson regression were performed to investigate the developments of SIRs and SMRs. To investigate differences in stage at diagnosis, logistic regression was performed, calculating Odds Ratios for condensed cancer stages. We observed higher incidence and mortality of stomach cancer [SIR (men) 1.62, 95%CI 1.17-2.19; SMR (men) 1.62, 95%CI 1.31-2.01; SIR (women) 1.32, 95%CI 0.86-1.94; SMR (women) 1.52, 95%CI 1.19-1.93] and higher mortality of lung cancer [SMR (men) 1.34, 95%CI 1.20-1.50] among resettlers compared to the general German population, but lower incidence and mortality of colorectal (both sexes), lung (women), prostate and female breast cancer. However, time trend analyses showed converging incidence risks of cause-specific incidence over time, whereas differences of mortality did not show changes over time. Results from logistic regression suggest that resettler men were more often diagnosed with advanced cancer stages compared to the Münster population. Our findings suggest that risk factor patterns of the most common cancer-sites among resettlers are similar to those observed within the Russian population. Such increases in prostate, colorectal and breast cancer incidence may be the consequence of improved detection measures, and/or the adaptation of resettlers to the German lifestyle.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kaucher</LastName>                    <ForeName>Simone</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Epidemiology and Biostatistics, Institute of Public Health, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kajüter</LastName>                    <ForeName>Hiltraud</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiological Cancer Registry of North Rhine-Westphalia, Münster, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Becher</LastName>                    <ForeName>Heiko</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Epidemiology and Biostatistics, Institute of Public Health, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Winkler</LastName>                    <ForeName>Volker</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Epidemiology and Biostatistics, Institute of Public Health, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Front Oncol</MedlineTA>            <NlmUniqueID>101568867</NlmUniqueID>            <ISSNLinking>2234-943X</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Public Health. 2015 Apr;25(2):293-9</RefSource>                <PMID Version="1">25236371</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2010 Sep;46(14):2647-59</RefSource>                <PMID Version="1">20843493</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Jun;55(6-7):781-7</RefSource>                <PMID Version="1">22736156</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gesundheitswesen. 2012 Aug;74(8-9):e84-9</RefSource>                <PMID Version="1">22836935</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 1997 Aug 9;350(9075):383-8</RefSource>                <PMID Version="1">9259651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Gastroenterol Hepatol. 2016 Aug;28(8):863-70</RefSource>                <PMID Version="1">27187801</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Public Health. 2010 Feb 24;10:92</RefSource>                <PMID Version="1">20181232</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gastrointest Endosc Clin N Am. 2011 Oct;21(4):613-35</RefSource>                <PMID Version="1">21944414</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Migr. 1997;35(2):253-70</RefSource>                <PMID Version="1">12292384</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Public Health. 2018 Jan 17;18(1):148</RefSource>                <PMID Version="1">29343242</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol. 2014 Feb;38(1):22-7</RefSource>                <PMID Version="1">24275258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Public Health. 2014 Feb;24(1):127-33</RefSource>                <PMID Version="1">23729483</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2014 Jan 8;311(2):183-92</RefSource>                <PMID Version="1">24399557</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med Res Methodol. 2017 Apr 12;17(1):55</RefSource>                <PMID Version="1">28403811</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13</RefSource>                <PMID Version="1">24618998</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Public Health. 2005;26:1-35</RefSource>                <PMID Version="1">15760279</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Public Health Rev. 2016 Jul 30;37:4</RefSource>                <PMID Version="1">29450046</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Emerg Themes Epidemiol. 2011 Aug 15;8(1):6</RefSource>                <PMID Version="1">21843354</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Public Health. 2012 Mar 13;12:190</RefSource>                <PMID Version="1">22413759</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2005 Mar 19-25;365(9464):1099-104</RefSource>                <PMID Version="1">15781105</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 1990 Aug 15;46(2):228-32</RefSource>                <PMID Version="1">2384272</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gesundheitswesen. 2001 Jun;63(6):376-82</RefSource>                <PMID Version="1">11467220</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Equity Health. 2010 Jun 11;9:15</RefSource>                <PMID Version="1">20540769</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Epidemiology. 1995 Mar;6(2):181-3</RefSource>                <PMID Version="1">7742407</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2905-13</RefSource>                <PMID Version="1">16365008</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Epidemiol. 2017 Apr;32(4):289-298</RefSource>                <PMID Version="1">28314982</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Germany</Keyword>            <Keyword MajorTopicYN="N">cancer</Keyword>            <Keyword MajorTopicYN="N">cohort study</Keyword>            <Keyword MajorTopicYN="N">former soviet union</Keyword>            <Keyword MajorTopicYN="N">incidence</Keyword>            <Keyword MajorTopicYN="N">migrants</Keyword>            <Keyword MajorTopicYN="N">mortality</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30254988</ArticleId>            <ArticleId IdType="doi">10.3389/fonc.2018.00378</ArticleId>            <ArticleId IdType="pmc">PMC6141734</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>